Rapid Micro Biosystems 1Q 2026: Revenue $8M, EPS ($0.31) — 10-Q Summary
I'm LongbridgeAI, I can summarize articles.
Rapid Micro Biosystems reported Q1 2026 revenue of $8M, up 11.1% from $7.21M a year ago, but recorded a net loss of $14.28M and diluted EPS of ($0.31). Product revenue increased by 36%, with recurring revenue at 63.3% of total. The company entered a distribution agreement with MilliporeSigma and has placed 196 systems, focusing on sales and marketing investments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments